On Thursday shares of Endocyte, Inc. (NASDAQ:ECYT) closed at $6.02. Company’s sales growth for last 5 years was 88.00%. Endocyte, Inc. (NASDAQ:ECYT) on 7 May, announced financial results for the first quarter ending March 31, 2015, and provided a clinical update. Cash, cash equivalents and investments were $196.8 million at March 31, 2015, compared to $206.8 million at December 31, 2014, and $131.5 million at March 31, 2014.
Stemline Therapeutics, Inc. (NASDAQ:STML) in last trading activity increased 1.12% to close at $13.60. Company weekly performance is 0.97% while its quarterly performance stands at -4.02%. Stemline Therapeutics, Inc. (NASDAQ:STML) is -28.19% away from its 52 week high. Stemline Therapeutics Inc. (NASDAQ:STML) on 11 May, reported a loss of $7.7 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 46 cents. The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share. The biopharmaceutical company posted revenue of $121,000 in the period, which met Street forecasts.
On Thursday shares of Comcast Corporation (NASDAQ:CMCSA) closed at $56.54. Company’s sales growth for last 5 years was 14.00% and EPS growth for next 5 years is recorded as 16.67%. Comcast Corp. (NASDAQ:CMCSA) plans to hire 10,000 military veterans, reservists, and their spouses and domestic partners over the next three years – roughly 15 percent to 20 percent of all new employees, a Comcast human resources executive said Thursday.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) has 3.30% insider ownership while its institutional ownership stands at 78.50%. In last trading activity company’s stock closed at $65.96. Integra Lifesciences Holdings Corp (NASDAQ:IART) was upgraded by Zacks
from a “hold” rating to a “buy” rating in a research note issued on 5 May.
On last trading day AXIS Capital Holdings Limited (NYSE:AXS) increased 1.37% to close at $55.53. Its volatility for the week is 1.66% while volatility for the month is 1.75%. AXS’s sales growth for past 5 years was 6.80% and its EPS growth for past 5 years was 18.90%. AXIS Capital Holdings Limited (NYSE:AXS) monthly performance is 4.26%. It was reported on 11 May, that AXIS Capital Holdings Ltd. (NYSE:AXS), seeking to complete a merger with PartnerRe, is highlighting the prospects for growth of a combined company.